| Patents for A61K 51 - Preparations containing radioactive substances for use in therapy or testing in vivo (24,291) |
|---|
| 05/07/1998 | WO1998018498A2 Improvements in or relating to diagnostic/therapeutic agents |
| 05/07/1998 | WO1998018497A2 Contrast agents |
| 05/07/1998 | WO1998018496A2 Contrast agents |
| 05/07/1998 | WO1998018495A2 Improvements in or relating to diagnostic/therapeutic agents |
| 05/07/1998 | WO1998010800A3 Labelled elastase inhibitors |
| 05/07/1998 | WO1997044461A3 Antigen binding fragments that specifically detect cancer cells, nucleotides encoding the fragments, and use thereof for the prophylaxis and detection of cancers |
| 05/07/1998 | CA2665133A1 Neutrokine .alpha. |
| 05/07/1998 | CA2270242A1 Process for the preparation of radiopharmaceuticals |
| 05/07/1998 | CA2270120A1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/07/1998 | CA2269985A1 Improvements in or relating to diagnostic/therapeutic agents |
| 05/06/1998 | EP0839059A1 Cardiotropic radiopharmaceuticals comprising a transition metal nitride complex and having rapid myocardial clearance |
| 05/06/1998 | EP0839055A1 Use of methioninase in anti-methionine and anti-homocysteine chemotherapy |
| 05/06/1998 | EP0692978A4 Radiopharmaceutical formulations having non-stannous reductants |
| 05/06/1998 | CN1180570A High polymer antineoplastic guide medicine and preparation method thereof |
| 05/05/1998 | US5747469 Methods and compositions comprising DNA damaging agents and p53 |
| 05/05/1998 | US5746997 Radiohalogenation of oligonucleotides via trialkylstannylaryl conjugates |
| 05/05/1998 | US5746996 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 05/05/1998 | US5746995 Diethylenetriaminepentaacetic acid |
| 05/05/1998 | CA1339853C Sf-25 colon adenocarcinoma antigen, and antibodies which recognize thisantigen |
| 04/30/1998 | WO1998017797A1 ANTI-ErbB2 ANTIBODIES |
| 04/30/1998 | WO1998017331A1 Silver implantable medical device |
| 04/29/1998 | EP0837696A1 Improved delivery of diagnostic and therapeutic agents to a target site |
| 04/29/1998 | EP0662005B1 Microparticle preparations made from biodegradable copolymers |
| 04/28/1998 | US5744120 Phosphine or arsine ligated technetium-99m labeled hydrazino or diazino modified biologically active molecules that selectively localize at sites of disease |
| 04/28/1998 | US5744119 Preparation of a radioconjugate formulation |
| 04/23/1998 | WO1998016254A1 Non-antigenic toxin-conjugate and fusion protein of internalizing receptor system |
| 04/23/1998 | WO1998008548A3 Stable radioiodine conjugates and methods for their synthesis |
| 04/22/1998 | EP0836618A1 Radiometal-binding analogues of leutenizing hormone releasing hormone |
| 04/22/1998 | EP0836418A1 Microfabricated devices for diagnostic applications |
| 04/22/1998 | EP0733206B1 Labelling of nucleic acid analogue-peptide chimerae |
| 04/22/1998 | EP0725633A4 Detection of h. pylori in the stomach |
| 04/21/1998 | US5741912 Diagnosis, therapy |
| 04/21/1998 | US5741670 Polypeptides |
| 04/21/1998 | US5741476 Polyhydric phenol compounds |
| 04/16/1998 | WO1998015295A2 Radiopharmaceuticals for imaging infection and inflammation |
| 04/16/1998 | WO1998015277A2 Cns-penetrant nk-1 receptor antagonists as antidepressant and/or an anti-anxiety agents |
| 04/16/1998 | WO1998009600A3 Novel silicon amphiphilic compounds and the use thereof |
| 04/16/1998 | CA2267767A1 Radiopharmaceuticals for imaging infection and inflammation |
| 04/16/1998 | CA2266773A1 Use of a nk-1 receptor antagonist and an antidepressant and/or an anti-anxiety agent |
| 04/15/1998 | EP0835263A2 Somatostatin peptides |
| 04/15/1998 | EP0835134A1 Immunoconjugates comprising single-chain variable region fragments of anti-cd-19 antibodies |
| 04/15/1998 | EP0821686A4 Novel porphyrins and porphyrin synthesis techniques |
| 04/15/1998 | EP0640130B1 Chimeric multivalent protein analogues and methods of use thereof |
| 04/15/1998 | CN1179106A Recombinant human alpha-fetoprotein and uses thereof |
| 04/14/1998 | US5739323 Carboxamide modified polyamine chelators and radioactive complexes thereof for conjugation to antibodies |
| 04/14/1998 | US5739313 Radionuclide labeling of vitamin B12 and coenzymes thereof |
| 04/14/1998 | US5739294 Bicyclopol yazamacrocyclophosphonic acid complexes for use as contrast agents |
| 04/14/1998 | US5738868 Adding stannous chloride reducing agent to a liposome under vacuum, dehydrating, rehydrating and adding radio-label to rehydrated liposome to form radio labelled liposome; used for image diagnosis of tumors, abscesses and ischemia |
| 04/14/1998 | US5738844 Polypeptides |
| 04/14/1998 | US5738838 Metal ion-binding domains are labeled with medically useful metal ions for lung imaging |
| 04/09/1998 | WO1998014220A2 TECHNETIUM-99m LABELED CHELATOR INCORPORATED CYCLIC PEPTIDES |
| 04/09/1998 | WO1998014219A2 A method for the reduction of oxygenated compounds of rhenium or technetium |
| 04/09/1998 | WO1997048804A3 Tie-2 receptor ligands (tie ligand-3; tie ligand-4) and their uses |
| 04/09/1998 | WO1997047329A3 Radiopharmaceutical compositions capable of localizing at sites of thrombus |
| 04/09/1998 | DE19641178A1 N-Di:hydroxypropyl 5-amino-2,4,6-tri:iodo-isophthalamide preparation |
| 04/09/1998 | CA2267467A1 Technetium-99m labeled chelator incorporated cyclic peptides that bind to the gpiib/iiia receptor as imaging agents |
| 04/08/1998 | EP0833646A1 Multi-tyrosinated somatostatin analogs |
| 04/08/1998 | EP0688313B1 Ligands and metal complexes thereof |
| 04/08/1998 | EP0558681B1 Treatment for tissue ulceration |
| 04/07/1998 | US5736394 Cellular uptake of modified peptides |
| 04/07/1998 | US5736137 Anticarcinogenic agents |
| 04/07/1998 | US5736122 A specific binding peptide having amino acid sequence of 4 to 100 amino acids and technitium-99m binding moiety covalently linked to specific binding peptide, where in peptide binds to a component of a thrombus |
| 04/07/1998 | US5736120 Method for preparing radiolabeled peptides |
| 04/07/1998 | US5736119 Using a naturally-occuring protein that chelated metal ions and has a molecular weight of at least 60,000 daltons |
| 04/02/1998 | WO1998012979A1 Method of treating a disease process in a luminal structure |
| 04/02/1998 | CA2267073A1 Method of treating a disease process in a luminal structure |
| 04/01/1998 | EP0832654A2 Radiation-protecting agent |
| 04/01/1998 | EP0832111A1 Modified avidin and streptavidin and methods of use thereof |
| 04/01/1998 | EP0832068A1 Stable reagents for the preparation of radiopharmaceuticals |
| 04/01/1998 | EP0831941A1 Iodinated neuroprobes for mapping monoamine reuptake sites |
| 04/01/1998 | EP0831939A1 Structurally determined metallo-constructs and applications |
| 04/01/1998 | EP0831938A1 Radiolabeled peptide compositions for site-specific targeting |
| 04/01/1998 | EP0831936A1 Thiolation of peptides for radionuclide-based radiodetection and radiotherapy |
| 04/01/1998 | EP0831933A1 Site specific binding system, imaging compositions and methods |
| 04/01/1998 | EP0831930A1 Chelating polymers as contrast agents for medical imaging |
| 04/01/1998 | EP0831905A1 Methods of treating colon cancer utilizing tumor-specific antibodies |
| 04/01/1998 | EP0831904A1 Treatment and diagnosis of prostate cancer |
| 04/01/1998 | EP0831892A1 Multimeric, recombinant urease vaccine |
| 03/31/1998 | US5734011 Ligand precursors for incorporation into peptides |
| 03/31/1998 | US5733903 Treatment of neoplastic tissue by water-soluble texaphyrine metal complexes |
| 03/26/1998 | WO1998011923A1 Identification of agents that protect against inflammatory injury to neurons |
| 03/26/1998 | CA2265896A1 Identification of agents that protect against inflammatory injury to neurons |
| 03/25/1998 | CN1176828A Method for preparing various kinds of In-BLMC kit |
| 03/25/1998 | CN1037817C Method for mfg. medicine box of kidney function developer |
| 03/24/1998 | US5731159 Heat stable receptor protein contacted with detectable antibodies |
| 03/24/1998 | US5730982 Therapeutic use of hypervariable region of monoclonal antibody M195 and constructs thereof |
| 03/24/1998 | US5730968 Amide-linked polyoxyalkylene glycols; cytotoxic agents; medical diagnosis, magnetic resonance imaging |
| 03/24/1998 | US5730759 Poly-substituted phthalocyanines |
| 03/24/1998 | CA1339775C Antibody 0.5b to hiv-i gp 120 modified with toxic substance |
| 03/19/1998 | WO1998011224A1 Tnf-beta-like protein for treating prostate cancer, and related nucleic acid molecules, pharmaceutical compositions and methods |
| 03/19/1998 | WO1998011223A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 03/19/1998 | WO1998010800A2 Labelled elastase inhibitors |
| 03/19/1998 | WO1998010795A2 Tumor homing molecules, conjugates derived therefrom, and methods of using same |
| 03/19/1998 | CA2265945A1 Labelled elastase inhibitors |
| 03/19/1998 | CA2265927A1 Monoclonal antibodies against the extracellular domain of human vegf-receptor protein (kdr) |
| 03/18/1998 | EP0828521A1 Sequestered imaging agents |
| 03/18/1998 | EP0624097B1 Targeting radioactive immunoreagents |
| 03/18/1998 | EP0509026B1 Use of an anticoagulant as a diagnostic agent |
| 03/17/1998 | US5728843 Positron emission tomography(pet) to differentiate metabolically active hypoxic tumor cells |
| 03/17/1998 | US5728821 Mutant BR96 antibodies reactive with human carcinomas |